This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Merck Sharp & Dohme LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Brett R Ambler - Innovator in Anti-Viral Compounds
Introduction
Brett R Ambler is an inventor based in Philadelphia, PA (US). He is known for his work in developing compounds aimed at combating viral infections. His research focuses on inhibitors of human respiratory syncytial virus (hRSV) and metapneumovirus (hMPV).
Latest Patent Applications
Brett R Ambler has submitted a patent application titled "INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS." This application details compounds of Formula I and their potential use as anti-viral agents for inhibiting the replication of hRSV and hMPV. The application emphasizes the importance of these compounds in the treatment and prophylaxis of hRSV and hMPV infections.
Conclusion
Brett R Ambler's contributions to the field of anti-viral research highlight his commitment to developing innovative solutions for viral infections. His ongoing work in this area may lead to significant advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile